Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-14 Sale | 2026-04-16 6:30 pm | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 1,347 | $90 | $121,230 | 50,195 (Direct) | View |
| 2026-04-09 Sale | 2026-04-10 4:45 pm | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 10,264 | $87.47 | $897,782 | 149,042 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-09 Exercise | 2026-04-10 4:45 pm | N/A 2035-04-07 | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 2,500 | $0 | 149,042 (Direct) | View |
| 2026-04-09 Exercise | 2026-04-10 4:45 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 2,500 | $21.05 | 149,042 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 6:00 pm | N/A 2036-03-01 | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 27,675 | $0 | 77,756 (Direct) | View |
| 2025-04-08 Option Award | 2025-04-09 08:05 am | N/A 2035-04-07 | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 150,000 | $0 | 150,081 (Direct) | View |
Ownership | 2025-04-09 08:00 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 0 | $0 | 81 (Direct) | View |